| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| 2413.T - M3, Inc. | HOLD | 0 @ JPY 17.2299 | JPY 0 | The current share valuation price of 2413.T based on adjusted close was JPY 17.2299. The average price that 2413.T shares were previous bought at was JPY 14.2637. The current market price is 20.8% higher than average price they were purchased at. The value of the holding in 2413.T has fallen by JPY 11,805 (USD $76) compared to the previous valuation of M3, Inc. |
| 4151.T - Kyowa Kirin Co., Ltd. | HOLD | 0 @ JPY 16.1023 | JPY 0 | The current share valuation price of 4151.T based on adjusted close was JPY 16.1023. The average price that 4151.T shares were previous bought at was JPY 15.513. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in 4151.T has fallen by JPY 3,124 (USD $20) compared to the previous valuation of Kyowa Kirin Co., Ltd. |
| 4502.T - Takeda Pharmaceutical Company Limited | HOLD | 0 @ JPY 28.171 | JPY 0 | The current share valuation price of 4502.T based on adjusted close was JPY 28.171. The average price that 4502.T shares were previous bought at was JPY 28.7966. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in 4502.T has fallen by JPY 19,866 (USD $129) compared to the previous valuation of Takeda Pharmaceutical Company Limited |
| 4503.T - Astellas Pharma Inc. | HOLD | 0 @ JPY 12.2169 | JPY 0 | The current share valuation price of 4503.T based on adjusted close was JPY 12.2169. The average price that 4503.T shares were previous bought at was JPY 10.6945. The current market price is 14.2% higher than average price they were purchased at. The value of the holding in 4503.T has fallen by JPY 28,902 (USD $187) compared to the previous valuation of Astellas Pharma Inc. |
| 4507.T - Shionogi & Co., Ltd. | HOLD | 0 @ JPY 17.3008 | JPY 0 | The current share valuation price of 4507.T based on adjusted close was JPY 17.3008. The average price that 4507.T shares were previous bought at was JPY 16.8344. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in 4507.T has fallen by JPY 5,979 (USD $39) compared to the previous valuation of Shionogi & Co., Ltd. |
| 4519.T - Chugai Pharmaceutical Co., Ltd. | HOLD | 0 @ JPY 54.7891 | JPY 0 | The current share valuation price of 4519.T based on adjusted close was JPY 54.7891. The average price that 4519.T shares were previous bought at was JPY 45.8615. The current market price is 19.5% higher than average price they were purchased at. The value of the holding in 4519.T has increased by JPY 219,029 (USD $1,417) compared to the previous valuation of Chugai Pharmaceutical Co., Ltd. however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| 4523.T - Eisai Co., Ltd. | HOLD | 0 @ JPY 30.1234 | JPY 0 | The current share valuation price of 4523.T based on adjusted close was JPY 30.1234. The average price that 4523.T shares were previous bought at was JPY 30.3993. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in 4523.T has increased by JPY 33,424 (USD $216) compared to the previous valuation of Eisai Co., Ltd. however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| 4543.T - Terumo Corporation | HOLD | 0 @ JPY 15.4805 | JPY 0 | The current share valuation price of 4543.T based on adjusted close was JPY 15.4805. The average price that 4543.T shares were previous bought at was JPY 16.7591. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in 4543.T has increased by JPY 3,056 (USD $20) compared to the previous valuation of Terumo Corporation however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| 4568.T - Daiichi Sankyo Company, Limited | HOLD | 0 @ JPY 22.4298 | JPY 0 | The current share valuation price of 4568.T based on adjusted close was JPY 22.4298. The average price that 4568.T shares were previous bought at was JPY 27.6546. The current market price is -18.9% lower than average price they were purchased at. The value of the holding in 4568.T has fallen by JPY 69,078 (USD $447) compared to the previous valuation of Daiichi Sankyo Company, Limited |
| 4578.T - Otsuka Holdings Co., Ltd. | HOLD | 0 @ JPY 54.1641 | JPY 0 | The current share valuation price of 4578.T based on adjusted close was JPY 54.1641. The average price that 4578.T shares were previous bought at was JPY 55.5796. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in 4578.T has fallen by JPY 68 (USD $0) compared to the previous valuation of Otsuka Holdings Co., Ltd. |
| 6869.T - Sysmex Corporation | HOLD | 0 @ JPY 9.85857 | JPY 0 | The current share valuation price of 6869.T based on adjusted close was JPY 9.85857. The average price that 6869.T shares were previous bought at was JPY 12.5573. The current market price is -21.5% lower than average price they were purchased at. The value of the holding in 6869.T has fallen by JPY 54,149 (USD $350) compared to the previous valuation of Sysmex Corporation |
| 7733.T - Olympus Corporation | HOLD | 0 @ JPY 13.3058 | JPY 0 | The current share valuation price of 7733.T based on adjusted close was JPY 13.3058. The average price that 7733.T shares were previous bought at was JPY 12.6166. The current market price is 5.5% higher than average price they were purchased at. The value of the holding in 7733.T has fallen by JPY 8,042 (USD $52) compared to the previous valuation of Olympus Corporation |
| 7741.T - HOYA Corporation | HOLD | 0 @ JPY 154.129 | JPY 0 | The current share valuation price of 7741.T based on adjusted close was JPY 154.129. The average price that 7741.T shares were previous bought at was JPY 135.742. The current market price is 13.5% higher than average price they were purchased at. The value of the holding in 7741.T has fallen by JPY 17,568 (USD $114) compared to the previous valuation of HOYA Corporation |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 144.52 | USD 0 | The current share valuation price of A based on adjusted close was USD 144.52. The average price that A shares were previous bought at was USD 135.277. The current market price is 6.8% higher than average price they were purchased at. The value of the holding in A has fallen by USD 203,836 compared to the previous valuation of Agilent Technologies Inc |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 234 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 234. The average price that ABBV shares were previous bought at was USD 204.201. The current market price is 14.6% higher than average price they were purchased at. The value of the holding in ABBV has increased by USD 206,145 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 130.03 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 130.03. The average price that ABT shares were previous bought at was USD 132.169. The current market price is -1.6% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 45,669 compared to the previous valuation of Abbott Laboratories |
| ALC.SW - | HOLD | 0 @ CHF 77.1793 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 77.1793. The average price that ALC.SW shares were previous bought at was CHF 77.9566. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 84,451 (USD $106,324) compared to the previous valuation of |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 132.61 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 132.61. The average price that ALGN shares were previous bought at was USD 135.875. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in ALGN has fallen by USD 8,303 compared to the previous valuation of Align Technology Inc |
| ALNY - Alnylam Pharmaceuticals Inc | HOLD | 0 @ USD 460.54 | USD 0 | The current share valuation price of ALNY based on adjusted close was USD 460.54. The average price that ALNY shares were previous bought at was USD 414.737. The current market price is 11.0% higher than average price they were purchased at. The value of the holding in ALNY has increased by USD 86,784 compared to the previous valuation of Alnylam Pharmaceuticals Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 341.71 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 341.71. The average price that AMGN shares were previous bought at was USD 289.67. The current market price is 18.0% higher than average price they were purchased at. The value of the holding in AMGN has increased by USD 136,451 compared to the previous valuation of Amgen Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 919.026 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 919.026. The average price that ARGX.BR shares were previous bought at was EUR 714.954. The current market price is 28.5% higher than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 26,740 (USD $31,059) compared to the previous valuation of Argenx SE however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 179.095 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 179.095. The average price that AZN.L shares were previous bought at was GBP 133.937. The current market price is 33.7% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 227,896 (USD $299,914) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 17.77 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 17.77. The average price that BAX shares were previous bought at was USD 22.3875. The current market price is -20.6% lower than average price they were purchased at. The value of the holding in BAX has fallen by USD 7,298 compared to the previous valuation of Baxter International Inc |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 32.4106 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 32.4106. The average price that BAYN.DE shares were previous bought at was EUR 31.1449. The current market price is 4.1% higher than average price they were purchased at. The value of the holding in BAYN.DE has fallen by EUR 10,994 (USD $12,770) compared to the previous valuation of Bayer AG |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 190.98 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 190.98. The average price that BDX shares were previous bought at was USD 182.841. The current market price is 4.5% higher than average price they were purchased at. The value of the holding in BDX has fallen by USD 12,300 compared to the previous valuation of Becton Dickinson and Company |
| BIIB - Biogen Inc | HOLD | 0 @ USD 164.68 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 164.68. The average price that BIIB shares were previous bought at was USD 144.991. The current market price is 13.6% higher than average price they were purchased at. The value of the holding in BIIB has fallen by USD 8,363 compared to the previous valuation of Biogen Inc |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 123.403 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 123.403. The average price that BIM.PA shares were previous bought at was EUR 129.948. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 2,642 (USD $3,069) compared to the previous valuation of BioMerieux |
| BMRN - Biomarin Pharmaceutical Inc | HOLD | 0 @ USD 54.46 | USD 0 | The current share valuation price of BMRN based on adjusted close was USD 54.46. The average price that BMRN shares were previous bought at was USD 56.2324. The current market price is -3.2% lower than average price they were purchased at. The value of the holding in BMRN has fallen by USD 1,137 compared to the previous valuation of Biomarin Pharmaceutical Inc |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 46.81 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 46.81. The average price that BMY shares were previous bought at was USD 47.1527. The current market price is -0.7% lower than average price they were purchased at. The value of the holding in BMY has increased by USD 13,748 compared to the previous valuation of Bloomsbury Publishing Plc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 101.76 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 101.76. The average price that BSX shares were previous bought at was USD 101.398. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in BSX has fallen by USD 30,015 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 101.76 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 101.76. The average price that BSX shares were previous bought at was USD 101.398. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in BSX has fallen by USD 30,015 compared to the previous valuation of MULSTRXSSXIMETFP |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 206.18 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 206.18. The average price that CAH shares were previous bought at was USD 165.397. The current market price is 24.7% higher than average price they were purchased at. The value of the holding in CAH has increased by USD 59,917 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| CI - Cigna Corp | HOLD | 0 @ USD 271.33 | USD 0 | The current share valuation price of CI based on adjusted close was USD 271.33. The average price that CI shares were previous bought at was USD 292.391. The current market price is -7.2% lower than average price they were purchased at. The value of the holding in CI has increased by USD 71,816 compared to the previous valuation of Cigna Corp however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 37.08 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 37.08. The average price that CNC shares were previous bought at was USD 39.361. The current market price is -5.8% lower than average price they were purchased at. The value of the holding in CNC has increased by USD 81,666 compared to the previous valuation of Concurrent Technologies Plc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| COH.AX - | HOLD | 0 @ AUD 177.637 | AUD 0 | The current share valuation price of COH.AX based on adjusted close was AUD 177.637. The average price that COH.AX shares were previous bought at was AUD 185.498. The current market price is -4.2% lower than average price they were purchased at. The value of the holding in COH.AX has fallen by AUD 50,104 (USD $32,733) compared to the previous valuation of |
| COLO-B.CO - | HOLD | 0 @ DKK 89.1408 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 89.1408. The average price that COLO-B.CO shares were previous bought at was DKK 92.4839. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 121,370 (USD $18,881) compared to the previous valuation of |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 71.35 | USD 0 | The current share valuation price of COO based on adjusted close was USD 71.35. The average price that COO shares were previous bought at was USD 70.1887. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in COO has fallen by USD 3,078 compared to the previous valuation of The Cooper Companies, Inc. Common Stock |
| COR - Cencora Inc. | HOLD | 0 @ USD 365 | USD 0 | The current share valuation price of COR based on adjusted close was USD 365. The average price that COR shares were previous bought at was USD 318.212. The current market price is 14.7% higher than average price they were purchased at. The value of the holding in COR has increased by USD 149,068 compared to the previous valuation of Cencora Inc. however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| CSL.AX - | HOLD | 0 @ AUD 117.448 | AUD 0 | The current share valuation price of CSL.AX based on adjusted close was AUD 117.448. The average price that CSL.AX shares were previous bought at was AUD 132.252. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in CSL.AX has fallen by AUD 15,619 (USD $10,204) compared to the previous valuation of |
| CVS - CVS Health Corp | HOLD | 0 @ USD 78.41 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 78.41. The average price that CVS shares were previous bought at was USD 68.7988. The current market price is 14.0% higher than average price they were purchased at. The value of the holding in CVS has increased by USD 35,492 compared to the previous valuation of CVS Health Corp however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 33.2337 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 33.2337. The average price that DEMANT.CO shares were previous bought at was DKK 35.7818. The current market price is -7.1% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 20,152 (USD $3,135) compared to the previous valuation of |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 186.19 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 186.19. The average price that DGX shares were previous bought at was USD 180.581. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in DGX has fallen by USD 1,658 compared to the previous valuation of Quest Diagnostics Incorporated |
| DHR - Danaher Corporation | HOLD | 0 @ USD 220.44 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 220.44. The average price that DHR shares were previous bought at was USD 198.694. The current market price is 10.9% higher than average price they were purchased at. The value of the holding in DHR has fallen by USD 23,543 compared to the previous valuation of Danaher Corporation |
| DHR - Danaher Corporation | HOLD | 0 @ USD 220.44 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 220.44. The average price that DHR shares were previous bought at was USD 198.694. The current market price is 10.9% higher than average price they were purchased at. The value of the holding in DHR has fallen by USD 23,543 compared to the previous valuation of Danaher Corporation |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 220.42 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 220.42. The average price that DIM.PA shares were previous bought at was EUR 220.877. The current market price is -0.2% lower than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 4,648 (USD $5,399) compared to the previous valuation of Sartorius Stedim Biotech |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 117.27 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 117.27. The average price that DVA shares were previous bought at was USD 128.185. The current market price is -8.5% lower than average price they were purchased at. The value of the holding in DVA has fallen by USD 8,363 compared to the previous valuation of DaVita HealthCare Partners Inc |
| DXCM - DexCom Inc | HOLD | 0 @ USD 58.49 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 58.49. The average price that DXCM shares were previous bought at was USD 71.3092. The current market price is -18.0% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 4,403 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 366.033 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 366.033. The average price that EL.PA shares were previous bought at was EUR 319.13. The current market price is 14.7% higher than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 37,499 (USD $43,556) compared to the previous valuation of EssilorLuxottica SA |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 330.91 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 330.91. The average price that ELV shares were previous bought at was USD 381.913. The current market price is -13.4% lower than average price they were purchased at. The value of the holding in ELV has increased by USD 207,487 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 330.91 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 330.91. The average price that ELV shares were previous bought at was USD 381.913. The current market price is -13.4% lower than average price they were purchased at. The value of the holding in ELV has increased by USD 207,487 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 68.1035 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 68.1035. The average price that ERF.PA shares were previous bought at was EUR 54.3413. The current market price is 25.3% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 1,482 (USD $1,721) compared to the previous valuation of Eurofins Scientific SE |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 84.74 | USD 0 | The current share valuation price of EW based on adjusted close was USD 84.74. The average price that EW shares were previous bought at was USD 78.2923. The current market price is 8.2% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 190,883 compared to the previous valuation of Edwards Lifesciences Corp |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 46.4964 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 46.4964. The average price that FME.DE shares were previous bought at was EUR 51.4499. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 2,528 (USD $2,936) compared to the previous valuation of Fresenius Medical Care AG |
| FPH.NZ - | HOLD | 0 @ NZD 20.975 | NZD 0 | The current share valuation price of FPH.NZ based on adjusted close was NZD 20.975. The average price that FPH.NZ shares were previous bought at was NZD 21.107. The current market price is -0.6% lower than average price they were purchased at. The value of the holding in FPH.NZ has fallen by NZD 5,039 (USD $2,860) compared to the previous valuation of |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 56.6562 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 56.6562. The average price that FRE.DE shares were previous bought at was EUR 52.4661. The current market price is 8.0% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 698 (USD $811) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 184.024 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 184.024. The average price that GALD.SW shares were previous bought at was CHF 173.378. The current market price is 6.1% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 11,619 (USD $14,628) compared to the previous valuation of |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 70.6301 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 70.6301. The average price that GEHC shares were previous bought at was USD 78.2367. The current market price is -9.7% lower than average price they were purchased at. The value of the holding in GEHC has fallen by USD 23,466 compared to the previous valuation of GE HealthCare Technologies Inc. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 124.09 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 124.09. The average price that GILD shares were previous bought at was USD 115.808. The current market price is 7.2% higher than average price they were purchased at. The value of the holding in GILD has fallen by USD 141,103 compared to the previous valuation of Guild Esports Plc |
| GMAB.CO - | HOLD | 0 @ DKK 306.79 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 306.79. The average price that GMAB.CO shares were previous bought at was DKK 284.143. The current market price is 8.0% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 63,380 (USD $9,860) compared to the previous valuation of however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 12.2765 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 12.2765. The average price that GRF.MC shares were previous bought at was EUR 13.372. The current market price is -8.2% lower than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 2,092 (USD $2,430) compared to the previous valuation of Grifols SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 23.7111 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 23.7111. The average price that GSK.L shares were previous bought at was GBP 21.6478. The current market price is 9.5% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 22,841 (USD $30,059) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 477.1 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 477.1. The average price that HCA shares were previous bought at was USD 436.774. The current market price is 9.2% higher than average price they were purchased at. The value of the holding in HCA has increased by USD 17,431 compared to the previous valuation of HCA Holdings Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 20.7794 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 20.7794. The average price that HIK.L shares were previous bought at was GBP 24.113. The current market price is -13.8% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 614 (USD $808) compared to the previous valuation of however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.86872 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.86872. The average price that HLN.L shares were previous bought at was GBP 4.94029. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 3,897 (USD $5,129) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.14 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.14. The average price that HOLX shares were previous bought at was USD 70.0245. The current market price is 5.9% higher than average price they were purchased at. The value of the holding in HOLX has fallen by USD 891 compared to the previous valuation of Hologic Inc |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 234.11 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 234.11. The average price that HUM shares were previous bought at was USD 302.069. The current market price is -22.5% lower than average price they were purchased at. The value of the holding in HUM has fallen by USD 55,378 compared to the previous valuation of Hummingbird Resources PLC |
| HUM - Humana Inc | HOLD | 0 @ USD 234.11 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 234.11. The average price that HUM shares were previous bought at was USD 302.069. The current market price is -22.5% lower than average price they were purchased at. The value of the holding in HUM has fallen by USD 55,378 compared to the previous valuation of Humana Inc |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 669 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 669. The average price that IDXX shares were previous bought at was USD 606.673. The current market price is 10.3% higher than average price they were purchased at. The value of the holding in IDXX has fallen by USD 329,543 compared to the previous valuation of IDEXX Laboratories Inc |
| ILMN - Illumina Inc | HOLD | 0 @ USD 120.08 | USD 0 | The current share valuation price of ILMN based on adjusted close was USD 120.08. The average price that ILMN shares were previous bought at was USD 100.693. The current market price is 19.3% higher than average price they were purchased at. The value of the holding in ILMN has fallen by USD 1,819 compared to the previous valuation of Illumina Inc |
| INCY - Incyte Corporation | HOLD | 0 @ USD 104.17 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 104.17. The average price that INCY shares were previous bought at was USD 89.2644. The current market price is 16.7% higher than average price they were purchased at. The value of the holding in INCY has increased by USD 71 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 151.47 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 151.47. The average price that IPN.PA shares were previous bought at was EUR 135.278. The current market price is 12.0% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 2,747 (USD $3,191) compared to the previous valuation of Ipsen SA |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 216.12 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 216.12. The average price that IQV shares were previous bought at was USD 200.321. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in IQV has fallen by USD 226,040 compared to the previous valuation of IQVIA Holdings Inc |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 546.71 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 546.71. The average price that ISRG shares were previous bought at was USD 530.349. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in ISRG has fallen by USD 55,362 compared to the previous valuation of Intuitive Surgical Inc |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 199.58 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 199.58. The average price that JNJ shares were previous bought at was USD 167.147. The current market price is 19.4% higher than average price they were purchased at. The value of the holding in JNJ has increased by USD 519,833 compared to the previous valuation of Johnson & Johnson however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 261.37 | USD 0 | The current share valuation price of LH based on adjusted close was USD 261.37. The average price that LH shares were previous bought at was USD 263.732. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in LH has fallen by USD 9,208 compared to the previous valuation of Laboratory Corporation of America Holdings |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 1021.7 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 1021.7. The average price that LLY shares were previous bought at was USD 825.812. The current market price is 23.7% higher than average price they were purchased at. The value of the holding in LLY has fallen by USD 221,054 compared to the previous valuation of Eli Lilly and Company |
| LONN.SW - | HOLD | 0 @ CHF 678.021 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 678.021. The average price that LONN.SW shares were previous bought at was CHF 676.676. The current market price is 0.2% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 11,802 (USD $14,859) compared to the previous valuation of |
| MCK - McKesson Corporation | HOLD | 0 @ USD 855.23 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 855.23. The average price that MCK shares were previous bought at was USD 773.946. The current market price is 10.5% higher than average price they were purchased at. The value of the holding in MCK has increased by USD 270,448 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 96.28 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 96.28. The average price that MDT shares were previous bought at was USD 91.6287. The current market price is 5.1% higher than average price they were purchased at. The value of the holding in MDT has increased by USD 11,060 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| MOH - MOH | HOLD | 0 @ USD 136.79 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 136.79. The average price that MOH shares were previous bought at was USD 201.322. The current market price is -32.1% lower than average price they were purchased at. The value of the holding in MOH has fallen by USD 10,986 compared to the previous valuation of MOH |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 136.79 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 136.79. The average price that MOH shares were previous bought at was USD 201.322. The current market price is -32.1% lower than average price they were purchased at. The value of the holding in MOH has fallen by USD 10,986 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 92.86 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 92.86. The average price that MRK shares were previous bought at was USD 89.6219. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in MRK has fallen by USD 8,464 compared to the previous valuation of Marks Electrical Group PLC |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 92.86 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 92.86. The average price that MRK shares were previous bought at was USD 89.6219. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in MRK has fallen by USD 8,464 compared to the previous valuation of Merck & Company Inc |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 134.247 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 134.247. The average price that MRK.DE shares were previous bought at was EUR 130.82. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 5,753 (USD $6,682) compared to the previous valuation of Merck KGaA |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1388.96 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1388.96. The average price that MTD shares were previous bought at was USD 1324.02. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in MTD has fallen by USD 5,846 compared to the previous valuation of Mettler-Toledo International Inc |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1388.96 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1388.96. The average price that MTD shares were previous bought at was USD 1324.02. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in MTD has fallen by USD 5,846 compared to the previous valuation of AMUNDI EUR GOV 710 |
| NBIX - Neurocrine Biosciences Inc | HOLD | 0 @ USD 143.56 | USD 0 | The current share valuation price of NBIX based on adjusted close was USD 143.56. The average price that NBIX shares were previous bought at was USD 140.876. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in NBIX has fallen by USD 2,842 compared to the previous valuation of Neurocrine Biosciences Inc |
| NOVN.SW - | HOLD | 0 @ CHF 132.965 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 132.965. The average price that NOVN.SW shares were previous bought at was CHF 122.389. The current market price is 8.6% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 334,842 (USD $421,567) compared to the previous valuation of however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 48.5616 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 48.5616. The average price that NOVO-B.CO shares were previous bought at was DKK 56.1956. The current market price is -13.6% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 62,432 (USD $9,712) compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| NTRA - Natera Inc | HOLD | 0 @ USD 206.04 | USD 0 | The current share valuation price of NTRA based on adjusted close was USD 206.04. The average price that NTRA shares were previous bought at was USD 170.421. The current market price is 20.9% higher than average price they were purchased at. The value of the holding in NTRA has increased by USD 5,319 compared to the previous valuation of Natera Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 69.762 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 69.762. The average price that ORNBV.HE shares were previous bought at was EUR 67.2304. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 374 (USD $434) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| PFE - Pfizer Inc | HOLD | 0 @ USD 25.08 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 25.08. The average price that PFE shares were previous bought at was USD 24.6374. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in PFE has increased by USD 4,214 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 28.2295 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 28.2295. The average price that PHIA.AS shares were previous bought at was EUR 26.5931. The current market price is 6.2% higher than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 9,898 (USD $11,497) compared to the previous valuation of Koninklijke Philips NV |
| PME.AX - | HOLD | 0 @ AUD 168.817 | AUD 0 | The current share valuation price of PME.AX based on adjusted close was AUD 168.817. The average price that PME.AX shares were previous bought at was AUD 181.054. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in PME.AX has increased by AUD 8,567 (USD $5,597) compared to the previous valuation of however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 328.02 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 328.02. The average price that PODD shares were previous bought at was USD 313.923. The current market price is 4.5% higher than average price they were purchased at. The value of the holding in PODD has fallen by USD 6,557 compared to the previous valuation of Insulet Corporation |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 44.2464 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 44.2464. The average price that QIA.DE shares were previous bought at was EUR 45.509. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 6,338 (USD $7,362) compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 60.5996 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 60.5996. The average price that REC.MI shares were previous bought at was EUR 58.4047. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 3,322 (USD $3,859) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 704.31 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 704.31. The average price that REGN shares were previous bought at was USD 594.545. The current market price is 18.5% higher than average price they were purchased at. The value of the holding in REGN has increased by USD 33,738 compared to the previous valuation of Regeneron Pharmaceuticals Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| RMD - ResMed Inc | HOLD | 0 @ USD 244.71 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 244.71. The average price that RMD shares were previous bought at was USD 264.031. The current market price is -7.3% lower than average price they were purchased at. The value of the holding in RMD has increased by USD 772 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 377.098 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 377.098. The average price that RO.SW shares were previous bought at was CHF 341.923. The current market price is 10.3% higher than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 12,525 (USD $15,769) compared to the previous valuation of |
| ROG.SW - | HOLD | 0 @ CHF 361.008 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 361.008. The average price that ROG.SW shares were previous bought at was CHF 325.693. The current market price is 10.8% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 10,073 (USD $12,682) compared to the previous valuation of however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| RPRX - Royalty Pharma Plc | HOLD | 0 @ USD 39.16 | USD 0 | The current share valuation price of RPRX based on adjusted close was USD 39.16. The average price that RPRX shares were previous bought at was USD 36.5322. The current market price is 7.2% higher than average price they were purchased at. USD 0 compared to the previous valuation of Royalty Pharma Plc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 91.0599 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 91.0599. The average price that RVTY shares were previous bought at was USD 92.115. The current market price is -1.1% lower than average price they were purchased at. The value of the holding in RVTY has fallen by USD 5,216 compared to the previous valuation of Revvity Inc. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 104.254 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 104.254. The average price that SAN.PA shares were previous bought at was EUR 98.8748. The current market price is 5.4% higher than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 4,848 (USD $5,631) compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 69.034 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 69.034. The average price that SDZ.SW shares were previous bought at was CHF 57.1581. The current market price is 20.8% higher than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 772 (USD $972) compared to the previous valuation of |
| SHL.AX - | HOLD | 0 @ AUD 13.6754 | AUD 0 | The current share valuation price of SHL.AX based on adjusted close was AUD 13.6754. The average price that SHL.AX shares were previous bought at was AUD 14.8355. The current market price is -7.8% lower than average price they were purchased at. The value of the holding in SHL.AX has fallen by AUD 4,005 (USD $2,616) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 48.4564 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 48.4564. The average price that SHL.DE shares were previous bought at was EUR 53.8357. The current market price is -10.0% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 17,117 (USD $19,882) compared to the previous valuation of Siemens Healthineers AG |
| SIG.AX - | HOLD | 0 @ AUD 1.90714 | AUD 0 | The current share valuation price of SIG.AX based on adjusted close was AUD 1.90714. The average price that SIG.AX shares were previous bought at was AUD 1.9959. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in SIG.AX has fallen by AUD 3,418 (USD $2,233) compared to the previous valuation of |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 16.4047 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 16.4047. The average price that SN.L shares were previous bought at was GBP 17.6091. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 20 (USD $26) compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 35.5871 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 35.5871. The average price that SOBI.ST shares were previous bought at was SEK 31.2771. The current market price is 13.8% higher than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 4,049 (USD $429) compared to the previous valuation of |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 76.19 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 76.19. The average price that SOLV shares were previous bought at was USD 70.6839. The current market price is 7.8% higher than average price they were purchased at. The value of the holding in SOLV has increased by USD 1,986 compared to the previous valuation of Solventum Corp. however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 250.958 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 250.958. The average price that SOON.SW shares were previous bought at was CHF 278.783. The current market price is -10.0% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 90,047 (USD $113,369) compared to the previous valuation of |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 264.666 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 264.666. The average price that SRT3.DE shares were previous bought at was EUR 255.58. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 28,360 (USD $32,941) compared to the previous valuation of Sartorius AG |
| STE - STERIS plc | HOLD | 0 @ USD 257.01 | USD 0 | The current share valuation price of STE based on adjusted close was USD 257.01. The average price that STE shares were previous bought at was USD 226.428. The current market price is 13.5% higher than average price they were purchased at. The value of the holding in STE has fallen by USD 54,129 compared to the previous valuation of STERIS plc |
| STMN.SW - | HOLD | 0 @ CHF 123.462 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 123.462. The average price that STMN.SW shares were previous bought at was CHF 115.787. The current market price is 6.6% higher than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 7,599 (USD $9,567) compared to the previous valuation of |
| SYK - Stryker Corporation | HOLD | 0 @ USD 360.13 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 360.13. The average price that SYK shares were previous bought at was USD 370.433. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 14,642 compared to the previous valuation of Stryker Corporation |
| TEVA - Teva Pharma Industries Ltd ADR | HOLD | 0 @ USD 24.59 | USD 0 | The current share valuation price of TEVA based on adjusted close was USD 24.59. The average price that TEVA shares were previous bought at was USD 18.6802. The current market price is 31.6% higher than average price they were purchased at. The value of the holding in TEVA has fallen by USD 20,076 compared to the previous valuation of Teva Pharma Industries Ltd ADR |
| TMO - Time Out Group plc | HOLD | 0 @ USD 567.16 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 567.16. The average price that TMO shares were previous bought at was USD 475.692. The current market price is 19.2% higher than average price they were purchased at. The value of the holding in TMO has fallen by USD 243,070 compared to the previous valuation of Time Out Group plc |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 265.13 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 265.13. The average price that UCB.BR shares were previous bought at was EUR 207.476. The current market price is 27.8% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 39,598 (USD $45,994) compared to the previous valuation of UCB SA however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 320.52 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 320.52. The average price that UNH shares were previous bought at was USD 437.234. The current market price is -26.7% lower than average price they were purchased at. The value of the holding in UNH has fallen by USD 81,882 compared to the previous valuation of UnitedHealth Group Incorporated |
| UTHR - United Therapeutics Corporation | HOLD | 0 @ USD 471.92 | USD 0 | The current share valuation price of UTHR based on adjusted close was USD 471.92. The average price that UTHR shares were previous bought at was USD 420.31. The current market price is 12.3% higher than average price they were purchased at. The value of the holding in UTHR has increased by USD 4,891 compared to the previous valuation of United Therapeutics Corporation however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| VEEV - Veeva Systems Inc Class A | HOLD | 0 @ USD 277.01 | USD 0 | The current share valuation price of VEEV based on adjusted close was USD 277.01. The average price that VEEV shares were previous bought at was USD 285.857. The current market price is -3.1% lower than average price they were purchased at. The value of the holding in VEEV has fallen by USD 449,461 compared to the previous valuation of Veeva Systems Inc Class A |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 434.02 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 434.02. The average price that VRTX shares were previous bought at was USD 422.051. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in VRTX has fallen by USD 113,594 compared to the previous valuation of Vertex Pharmaceuticals Inc |
| WAT - Waters Corporation | HOLD | 0 @ USD 377.98 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 377.98. The average price that WAT shares were previous bought at was USD 338.317. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in WAT has fallen by USD 28,866 compared to the previous valuation of Waters Corporation |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 377.98 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 377.98. The average price that WAT shares were previous bought at was USD 338.317. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in WAT has fallen by USD 28,866 compared to the previous valuation of MULETFWATIMETFP |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 262.41 | USD 0 | The current share valuation price of WST based on adjusted close was USD 262.41. The average price that WST shares were previous bought at was USD 267.944. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in WST has increased by USD 1,552 compared to the previous valuation of West Pharmaceutical Services Inc however if the holding was sold on 2025-11-17 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 88.64 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 88.64. The average price that ZBH shares were previous bought at was USD 98.4616. The current market price is -10.0% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 5,253 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 118.8 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 118.8. The average price that ZTS shares were previous bought at was USD 141.646. The current market price is -16.1% lower than average price they were purchased at. The value of the holding in ZTS has fallen by USD 170,769 compared to the previous valuation of Zoetis Inc |